Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type
2 clinical trials · Condition
◉ Watch Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type
| Record | Firm | Date |
|---|---|---|
| Clinicopathologic and Ancillary Testing of Primary Clear Cell Carcinoma of the Cervix (NCT05046080) | M.D. Anderson Cancer Center | 2021-08-06 |
| Nivolumab and Ipilimumab in Treating Patients With Rare Tumors (NCT02834013) | National Cancer Institute (NCI) | 2017-01-30 |
Track Human Papillomavirus-Independent Cervical Adenocarcinoma, Clear Cell-Type automatically
Every clearance here is in the API, with alerts when new ones post.